2238 Iozzo, Renato V. - Thomas Jefferson University - Thomas Jefferson University
rvi101

Renato V. Iozzo, MD

Contact Dr. Iozzo

1020 Locust Street
Suite 336 Alumni Hall
Philadelphia, PA 19107

(215) 503-2208
(215) 923-7969 fax

Most Recent Peer-reviewed Publications

  1. Sortilin regulates progranulin action in castration-Resistant prostate cancer cells
  2. The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer
  3. Endorepellin evokes autophagy in endothelial cells
  4. Decorin induces mitophagy in breast carcinoma cells via peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) and mitostatin
  5. Decorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cells
  6. The injury response of aged tendons in the absence of biglycan and decorin
  7. FOXD1 promotes nephron progenitor differentiation by repressing decorin in the embryonic kidney
  8. Reprint of: Decorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cells
  9. The tendon injury response is influenced by decorin and biglycan
  10. Ligand-mediated endocytosis and trafficking of the insulin-like growth factor receptor I and insulin receptor modulate receptor function
  11. Decorin deficiency promotes hepatic carcinogenesis
  12. Biglycan and decorin differentially regulate signaling in the fetal membranes
  13. Instructive roles of extracellular matrix on autophagy
  14. The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling
  15. Osteoblastic cell secretome: A novel role for progranulin during risedronate treatment
  16. A decorin-deficient matrix affects skin chondroitin/dermatan sulfate levels and keratinocyte function
  17. Key roles fo 05E9 r the small leucine-rich proteoglycans in renal and pulmonary pathophysiology
  18. Cell-matrix interactions: Focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer
  19. Soluble biglycan as a biomarker of inflammatory renal diseases
  20. De novo expression of circulating biglycan evokes an innate inflammatory tissue response via MyD88/TRIF pathways
0